APA (7th ed.) Citation

JQ, Z., JZ, L., SW, Y., ZY, R., XY, Y., Z, L., . . . Q, H. (2024). Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma. Frontiers in endocrinology, 15, 1306091. https://doi.org/10.3389/fendo.2024.1306091

Chicago Style (17th ed.) Citation

JQ, Zhu, Liu JZ, Yang SW, Ren ZY, Ye XY, Liu Z, Li XL, Han DD, and He Q. "Impact of the Diagnosis of Metabolic Dysfunction-associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma." Frontiers in Endocrinology 15 (2024): 1306091. https://doi.org/10.3389/fendo.2024.1306091.

MLA (9th ed.) Citation

JQ, Zhu, et al. "Impact of the Diagnosis of Metabolic Dysfunction-associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma." Frontiers in Endocrinology, vol. 15, 2024, p. 1306091, https://doi.org/10.3389/fendo.2024.1306091.